Sequencing tags patients responding to everolimus; Parkinson's signature could help diagnosis;

> Using whole genome and targeted sequencing, researchers have found a genetic change that could be used to identify cancer patients most likely to respond to everolimus. This technique could be used to find similar markers for other cancer drugs. Article | Abstract

> A Parkinson's disease biomarker signature found using microarrays could be used for earlier diagnosis in patients with atypical symptoms. Abstract

> Markers could distinguish between forms of post kala-azar dermal leishmaniasis (PKDL). Abstract

> Deposits of calcium on blood vessel walls could help tag heart risk. Article

> Leptin, adiponectin and PAI-1 have potential as biomarkers to predict metabolic syndrome in teenagers, a growing problem worldwide. Abstract

> Researchers are still hunting down depression biomarkers, according to Genetic Engineering & Biotechnology News. Article

> Brain scans could tag epilepsy causes and treatments. Press release

And Finally… A new diabetes biosensor could test for glucose in saliva or tears. Article

Suggested Articles

Synthetic DNA weaver Twist Bioscience announced a handful of new collaborations this week amidst a $140 million raise from an underwritten offering.

The FDA has announced a series of actions aimed at limiting the use of power morcellators in gynecologic surgeries.

J&J launched a virtual clinical study to gauge whether Apple’s iPhone and ECG-enabled smartwatch can help reduce the risk of stroke and catch AFib.